Variant report
Variant | esv3320998 |
---|---|
Chromosome Location | chr1:192137857-192138505 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16834097 | chr1:192137858-192137859 | Weak transcription Genic enhancers Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs546946391 | chr1:192137890-192137891 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566760688 | chr1:192137891-192137892 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs149792935 | chr1:192137901-192137902 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185972970 | chr1:192137902-192137903 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146343113 | chr1:192137906-192137907 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537559822 | chr1:192137936-192137937 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557163860 | chr1:192137984-192137985 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189647358 | chr1:192137985-192137986 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530052006 | chr1:192138009-192138010 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564246772 | chr1:192138012-192138013 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536223088 | chr1:192138029-192138030 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553286572 | chr1:192138045-192138046 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573222941 | chr1:192138052-192138053 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10921101 | chr1:192138057-192138058 | Weak transcription Genic enhancers Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs200992279 | chr1:192138063-192138064 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375926213 | chr1:192138127-192138128 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186208054 | chr1:192138169-192138170 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1317071 | chr1:192138234-192138235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560801295 | chr1:192138243-192138244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529729840 | chr1:192138262-192138263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12141467 | chr1:192138277-192138278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545221435 | chr1:192138338-192138339 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78552690 | chr1:192138379-192138380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144239612 | chr1:192138415-192138416 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552457478 | chr1:192138440-192138441 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540978899 | chr1:192138475-192138476 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569072507 | chr1:192138483-192138484 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:192135200-192141400 | Enhancers | Dnd41 | blood |
2 | chr1:192135200-192141800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr1:192135800-192139200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr1:192136000-192139200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
5 | chr1:192136200-192138400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr1:192136200-192141600 | Enhancers | Primary hematopoietic stem cells | blood |
7 | chr1:192136400-192138200 | Genic enhancers | Primary monocytes fromperipheralblood | blood |
8 | chr1:192137000-192139200 | Enhancers | HUVEC | blood vessel |
9 | chr1:192137400-192139200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr1:192137400-192139200 | Weak transcription | Fetal Thymus | thymus |
11 | chr1:192137600-192139400 | Weak transcription | Primary T cells from cord blood | blood |
12 | chr1:192137800-192138800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
13 | chr1:192138000-192139200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr1:192138200-192141000 | Enhancers | Primary monocytes fromperipheralblood | blood |
15 | chr1:192138400-192140200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |